Centessa files 8-K referencing SerpinPC clinical update but no data in exhibit

Centessa Pharmaceuticals plc

Exhibit 99.1 only contains a title slide and standard disclaimers; no numerical results provided.
Presentation is posted on company website but not fully reproduced in the filing.
SerpinPC is an investigational serpin for haemophilia A/B with or without inhibitors.
No financial or guidance changes disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.